ONE-YEAR EFFECTIVENESS, RETENTION RATE AND SAFETY OF SECUKINUMAB IN ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS: A REAL-LIFE MULTICENTRE STUDY

被引：1
|
作者：
Chimenti, M. S. [1 ]
Fonti, G. L. [1 ]
Conigliaro, P. [1 ]
Sunzini, F. [1 ]
Scrivo, R. [2 ]
Navarini, L. [3 ]
Triggianese, P. [1 ]
Peluso, G. [4 ]
Scolieri, P. [5 ]
Caccavale, R. [6 ]
Picchianti-Diamanti, A. [7 ]
De Martino, E. [1 ]
Salemi, S. [7 ]
Birra, D. [4 ]
Altobelli, A. [2 ]
Paroli, M. [6 ]
Bruzzese, V. [5 ]
Lagana, B. [7 ]
Gremese, E. [4 ]
Conti, F. [2 ]
Afeltra, A. [3 ]
Perricone, R. [1 ]
机构：
[1] Univ Roma Tor Vergata, Rheumatol Allergol & Clin Immunol, Rome, Italy
[2] Sapienza Univ Roma, Reumatol, Dipartimento Med Interna & Specialita Med, Rome, Italy
[3] Univ Campus Biomed Roma, Dept Med, Unit Allergol Immunol & Rheumatol, Rome, Italy
[4] Univ Cattolica Sacro Cuore, Fdn Policlin Univ Agostino Gemelli, IRCCS Presidio Columbus, Ist Reumatol & Sci Affini, Rome, Italy
[5] Osped Nuovo Regina Margherita, UOC Med Interna & Reumatol, Rome, Italy
[6] Sapienza Univ Roma, Dipartimento Sci & Biotecnol Med Chirurg, Latina, Italy
[7] Sapienza Univ Rome, St Andrea Univ Hosp, Dept Clin & Mol Med, Rome, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.3777
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0270
引用
收藏
页码：716 / 716
页数：1
相关论文
共 50 条
  • [21] Effectiveness and safety of filgotinib in rheumatoid arthritis: a real-life multicentre experience
    La Barbera, L.
    Rizzo, C.
    Camarda, F.
    Atzeni, F.
    Miceli, G.
    Colella, A. B. Molica
    Franchina, V.
    Giardina, A.
    Corrao, S.
    Provenzano, G.
    Bursi, R.
    Foti, R.
    Dal Bosco, Y.
    Debilio, C.
    Luppino, F.
    Colaci, M.
    Aprile, M. L.
    Bentivegna, M.
    Cassara, E.
    Lo Gullo, A.
    De Andres, M. I.
    Guggino, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (05) : 991 - 998
  • [22] Real-Life Data of Secukinumab in Patients with Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis: Patient Baseline Characteristics Data from the PROMPT Study
    Rattanakaemakorn, Ploysyne
    Chevaisrakul, Parawee
    Wongpraparut, Chanisada
    Chiowchanwisawakit, Praveena
    Tovanabutra, Napatra
    Tantiwong, Pimchanok
    Amornpinyo, Warayuwadee
    Chakkavittumrong, Panlop
    Hanvivadhanakul, Punchong
    Chaiamnuay, Sumapa
    Laodheerasiri, Supapat
    Pattamadilok, Bensachee
    Choonhakarn, Charoen
    Mahakkanukrauh, Ajanee
    Aiewruengsurat, Duangkamol
    Sangmala, Siripan
    Pretikul, Nisa
    Sumethkul, Kittiwan
    Satpanich, Panchalee
    Boonsiri, Metavee
    Sangob, Naruemon
    Asawanonda, Pravit
    DERMATOLOGY AND THERAPY, 2024, 14 (12) : 3229 - 3241
  • [23] Effectiveness and safety of golimumab in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis under real-life clinical conditions: non-interventional GO-NICE study in Germany
    Krueger, Klaus
    Burmester, Gerd R.
    Wassenberg, Siegfried
    Bohl-Buehler, Martin
    Thomas, Matthias H.
    BMJ OPEN, 2018, 8 (06):
  • [24] Secukinumab in pregnancy: outcomes in psoriasis, psoriatic arthritis and ankylosing spondylitis from the global safety database
    Warren, R. B.
    Reich, K.
    Langley, R. G.
    Strober, B.
    Gladman, D.
    Deodhar, A.
    Bachhuber, T.
    Bao, W.
    Altemeyer, E.
    Hussain, S.
    Safi, J., Jr.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (05) : 1205 - 1207
  • [25] SECUKINUMAB IN PREGNANCY: OUTCOMES IN PSORIASIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS FROM THE GLOBAL SAFETY DATABASE
    Warren, Richard
    Reich, Kristian
    Langley, Richard
    Strober, Bruce
    Gladman, Dafna
    Deodhar, Atul
    Bachhuber, Teresa
    Bao, Weibin
    Altemeyer, Evelyn
    Hussain, Samina
    Safi, Jorge
    ACTA DERMATO-VENEREOLOGICA, 2018, 98 : 11 - 11
  • [26] Interim 2-Year Analysis from SERENA: A Real-World Study in Patients with Psoriatic Arthritis or Ankylosing Spondylitis Treated with Secukinumab
    Kiltz, Uta
    Sfikakis, Petros P.
    Gaffney, Karl
    Bounas, Andreas
    Gullick, Nicola
    Lespessailles, Eric
    Brandt-Juergens, Jan
    Rashkov, Rasho
    Schulz, Barbara
    Pournara, Effie
    Jagiello, Piotr
    RHEUMATOLOGY AND THERAPY, 2022, 9 (04) : 1129 - 1142
  • [27] Interim 2-Year Analysis from SERENA: A Real-World Study in Patients with Psoriatic Arthritis or Ankylosing Spondylitis Treated with Secukinumab
    Uta Kiltz
    Petros P. Sfikakis
    Karl Gaffney
    Andreas Bounas
    Nicola Gullick
    Eric Lespessailles
    Jan Brandt-Juergens
    Rasho Rashkov
    Barbara Schulz
    Effie Pournara
    Piotr Jagiello
    Rheumatology and Therapy, 2022, 9 : 1129 - 1142
  • [28] Undifferentiated spondyloarthritis vs ankylosing spondylitis and psoriatic arthritis: a real-life prospective cohort study of clinical presentation and response to treatment
    Paramarta, Jacqueline E.
    De Rycke, Leen
    Ambarus, Carmen A.
    Tak, Paul P.
    Baeten, Dominique
    RHEUMATOLOGY, 2013, 52 (10) : 1873 - 1878
  • [29] Three years of methotrexate and secukinumab: Outcomes of psoriatic arthritis in a real-life setting
    Nicola, Stefania
    Cassarino, Silvia Gallo
    Rolla, Giovanni
    Geronazzo, Giada
    Fornero, Monica
    Brussino, Luisa
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 86 (01) : 241 - 243
  • [30] EFFECTIVENESS AND SAFETY OF BIOSIMILAR INFLIXIMAB (CT-P13) IN A REAL-LIFE SETTING IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS
    Codreanu, C.
    Sirova, K.
    Jarosova, K.
    Batalov, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 489 - 489
12345